Oncologists and researchers use a measurement known as Response Evaluation Criteria in Solid Tumors (RECIST) to evaluate the degree to which a patient's cancer responds to treatment during clinical ...
Response Evaluation Criteria In Solid Tumours (RECIST) remain an integral part of the assessment of tumour burden in many clinical trials in oncology; these criteria are used to evaluate the activity ...
Predictive value of changes in plasma vascular endothelial growth factor at eight weeks after lenvatinib administration in patients with unresectable hepatocellular carcinoma. Complete responses (CR) ...
Enhancing the Quality of Hierarchic Relations in the National Cancer Institute Thesaurus to Enable Faceted Query of Cancer Registry Data We focused on pharmacotherapies and patient responses, using 55 ...
In 1963, 20 years after he first administered nitrogen mustard to a human, Yale pharmacologist Alfred Gilman recounted the previously top-secret clinical experiment for a surgical audience. He wrote: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results